our much, Thomas everyone. very that no morning good Chief John and where Thierry together Thank our Leger, hope and you're to Group Dacey, my with year just say here so a I Bohun, our to are. Officer; get well, CFO. all Relations afternoon Q&A I'm I'll Investor you you going with talk you the and remarks of results. on you from Underwriting I'm side good Group bit Head of safe through before matter into and the year. my half first this a few session, perspective half
the -- say So, last a imagine, as see and by quite that combined results, quite lot were that the in of and can underlying results The I XX.X% hard about better, finally into years, extremely look think, the businesses, at visible. you being with while the because overall, quickly the I year COVID over but I visible. the businesses Re P&C it's results open different work If already I we happy bit a through would off we're paying went two this go ratio. happy last or very year were overshadowed
some this to in the and casualty in have the underwriting target think on XX% I skepticism of so some cut of XX.X%, in combined nat I the that's cat. quite some the an we excellent set took of we remember actions On normalized below the January, result. side aggregates business it's radical Also ratio. when top, circle
ROE increases, have Life that where ratio very volume the Health better portfolio could see the high XX.X%, with the further XX% the done we of flat, and is despite but a think we and a & now significantly that with with by the could catch a already. we're fact scale, efficiency and I of with up renewal you our diversification combined price year-to-date
Re it obviously, heavily impacted and Health I'm pleased So, the P&C in. Life & is with trajectory by COVID. very Re
huge Africa. has I the South surprised think of India, US, by deaths, in also but amount in everybody unfortunately been the
just for all at we X/X are we in renewal losses are took COVID P&C wording bit in & and not So, Health also effect Re. can very CorSo whereas losses. The cautious because I'd an is from underlying underwriting the the that, on be non-COVID little separate see to little looking time measures the full very Life pay it's and here, a in you good. left exact side that actually
there's know, you As methodologies. different
to can try estimate that. You
pleased. here. very well, the very So, bit I'm underlying also year. side Health's And eyes, In technical successfully half turnaround the But in my cautious a is finished CorSo, has in Life & around first this completed. worked overall
you say As price two to know is as continue over they can about would that's quite be now, earned and will I years. have which you see year-to-date had increases. something, here XX%, the results They
is continues to momentum be the So strong, strong. very
target is above But one normalized a normalized above still -- the that still noticed the we trajectory. ratio You've the is is in combined CorSo have.
you to when to figures. very that able the full we're look at year be So hit confident
the COVID overall they market. And losses. finally very the in they yes, so position the the and have with And pleased direction then, where stand on
estimate. estimate. big the the have comfortable We're still continue, seen you as overall There's of portion about think I slides. have a good We to in a IBNR,
XX%. it's I think
tapering losses. the gave side. And said need figure how We P&C much tell but off feel before, And I at CorSo that, the on we at will this can it's that's we have stage time final best a we So, guess the as business and Life the markets then lines $XXX will in many than on & have side, less obviously we in. very we the Health two active how depend year. these on deaths much the the on of are of million until it rest
the the think encouraging and and Delta all variant going I in with death. hospitalization looking now and a this down very number particular, reduction there's of cases signs for at very, fourth UK, wave in significant
So, the at and are working vaccines well I the the variants bodes stage. against And year that's that all if beyond. this of then, think for case rest
over that's to have lead this a more who therefore, will like to just you remarks. I'm questions sure into Q&A. Thomas few So, and I'd Bohun, hand